A call for transparency, improved reporting, and interpretation of trials using surrogate end points in cardiac electrophysiology

By afschroeder • August 3, 2025

Tereshchenko LG, Manyara AM, Ciani O, Sodeke SO, Bradford CN, Santangeli P, Kapadia SR, Wazni O, Narayan SM, Chugh SS, Bilchick K, Huizar JF, Vaseghi M, Chung MK, Ellenbogen KA, Taylor RS. A call for transparency, improved reporting, and interpretation of trials using surrogate end points in cardiac electrophysiology. Heart Rhythm. 2025 Aug;22(8):e492-e499. doi: 10.1016/j.hrthm.2025.02.038. Epub 2025 Feb 26. PMID: 40021073; PMCID: PMC12317828.

Tags: Biomarker, Cardiology/Epi, Cedars Sinai DoM, Checklist, Clinical Trial, Outcome, Publications, Randomized Controlled Trial, Research design, standards, Surrogate end point, surrogate marker

Procedural and Functional Outcomes After Computer Assisted Vacuum Thrombectomy With the 16F Catheter System for Treatment of Pulmonary Embolism: A Subanalysis of the STRIKE-PE Study

Moriarty JM, Schiro BJ, Weinberg I, Dohad SY, Davis HC, Shavelle DM, Chrysant GS, Perkowski PE, Muck PE, Bishay VL, Holden A, West FM, Scheidt[...]

A Special Muscle Fiber Surviving After Septal Line Ablation of Mitral-Isthmus Dependent Atrial Flutter

Yamada T, Akrawinthawong K, Miyazaki Y, Mori S. A Special Muscle Fiber Surviving After Septal Line Ablation of Mitral-Isthmus Dependent Atrial Flutter. J Arrhythm. 2026[...]

Striking Surge in Lung Cancer Incidence in Children of Early Life

Zong NC, Johal J, Liu H, Cai H. Striking Surge in Lung Cancer Incidence in Children of Early Life. J Respir Biol Transl Med. 2026;3(2):10004.[...]